|LETTER TO THE EDITOR
|Year : 2014 | Volume
| Issue : 1 | Page : 117-118
Depression and type 2 diabetes in developed and developing countries
Salma Bensbaa1, Chadya Araab2, Saïd Boujraf3, Farida Ajdi1
1 Department of Endocrinology, Diabetology and Nutrition, University Hospital of Fez, Morocco
2 Department of Psychiatry; Clinical Neuroscience Laboratory, University of Fez, Morocco
3 Clinical Neuroscience Laboratory; Department of Biophysics and Clinical MRI Methods, Faculty of Medicine, University of Fez, Morocco
|Date of Web Publication||6-Feb-2014|
Department of Biophysics and Clinical MRI Methods, Faculty of Medicine, University of Fez
Source of Support: None, Conflict of Interest: None
|How to cite this article:|
Bensbaa S, Araab C, Boujraf S, Ajdi F. Depression and type 2 diabetes in developed and developing countries. Indian J Endocr Metab 2014;18:117-8
|How to cite this URL:|
Bensbaa S, Araab C, Boujraf S, Ajdi F. Depression and type 2 diabetes in developed and developing countries. Indian J Endocr Metab [serial online] 2014 [cited 2021 Mar 6];18:117-8. Available from: https://www.ijem.in/text.asp?2014/18/1/117/126592
Diabetes patients are more exposed to depression. This association might yield higher rates of mortality, morbidity and costs of health-care.  The world evaluation of depression prevalence in diabetes patients seems to vary according to the prosperity and health-care system of each country.  Hence, what are the factors of impact on the gap of depression rate within type 2 diabetes (T2D) in developing and developed countries? What are the care possibilities to reduce the depression rate in developing countries compared with developed countries?
To answer this question, we achieved a transversal study in the University Hospital of Fez, Morocco. The study included 142 T2D patients.
The average age of patients was 56.68-year-old, without significant difference in gender ration. The depression prevalence in our patients was 33.1%. Factors connected to the depression of MoroccanT2D are summarized in [Table 1].
The prevalence of T2D was significantly higher compared with the general population. It varies between 12% and 44%. Indeed, the prevalence of T2D is lower in western countries; it is elevated in developing countries. ,
The literature review revealed that depression of T2D patients is mostly associated to unchangeable factors such as the duration of evolution and arterial hypertension, which are common factors in developed and developing countries. 
Besides, depression of T2D patients is strongly connected the low educational level of patients, a lack of social security. These two factors are dominant in developing countries. 
Indeed, in developing countries factors such as lack of social, lower educational level, strong poverty level and resources and financial difficulties constitute the economical outline of stress responsible for insecurity feeling toward chronic disease such T2D.
Furthermore, the health-care of T2D patients might require referencing the patients to specialist that might be involved including psychiatrists, which are not available geographically within joint distance for many patients.
Therefore, we do consider the challenge of treatment approach of T2D patients. It is necessary to integrate diabetes within a framework of biopsychosocial and political approach.
We suggest integrating T2D patient in coordinated multidisciplinary strategy of health-care. This should include a health-care staff sensitive to the screening and managing the psychological state T2D patients and risk factors of the depression. This could be achieved through improving the general life condition including eradicating illiteracy and generalizing the social security for forward improvement of access to health-care.
| References|| |
|1.||Egede LE, Nietert PJ, Zheng D. Depression and all-cause and coronary heart disease mortality among adults with and without diabetes. Diabetes Care 2005;28:1339-45. |
|2.||Mezuk B, Eaton WW, Albrecht S, Golden SH. Depression and type 2 diabetes over the lifespan: A meta-analysis. Diabetes Care 2008;31:2383-90. |
|3.||Balhara YP, Sagar R. Correlates of anxiety and depression among patients with type 2 diabetes mellitus. Indian J Endocrinol Metab 2011;15:S50-4. |
|4.||Atlantis E, Vogelzangs N, Cashman K, Penninx BJ. Common mental disorders associated with 2-year diabetes incidence: The Netherlands Study of Depression and Anxiety. J Affect Disord. 2012 Oct; 142 Suppl: S30-5. |
|5.||Camara A, Sobngwi E, Moussa BN, Baldé S, Barry OT, Malal BM, et al. Anxiety and depression: Frequency and associated factors in 435 diabetic patients followed in Guinea. Diabetes and Metabolism. 2011;37:A36-108. |